I. Epidemiology of thyroid nodules A thyroid nodule is an isolated lesion within the thyroid gland that can be palpated and/or ultrasounded to distinguish it from surrounding thyroid tissue.
Thyroid nodules are the most common type of thyroid disorder. The prevalence varies depending on the screening method and the population enrolled. Physical examination and ultrasonography are currently the common screening methods, but the rate of nodule detection is influenced by the level and experience of the examiner. Epidemiological surveys have shown that the prevalence of palpation in iodine-sufficient areas is 5% in women and 1% in men. The highest prevalence of thyroid nodules was reported in the United States in a study that used high-definition ultrasound, and the detection rate of thyroid nodules was as high as 19-67% in a randomly selected population, with women and older adults being more common. There is a wide variation in whether nodules are more frequent than nodules, or more frequent than nodules. The proportion of thyroid cancer in thyroid nodules varies, with most reports accounting for about 5%, but there is an increasing trend in recent years.
The etiology of thyroid nodules is divided into two categories: benign and malignant. Including many thyroid diseases, benign thyroid nodules include: hyperplastic goiter (diffuse and nodular), toxic nodular goiter, thyroid adenoma, thyroid cyst, focal thyroiditis, etc. Malignant thyroid nodules include differentiated thyroid cancer (papillary thyroid cancer, follicular thyroid cancer), undifferentiated thyroid cancer, and medullary carcinoma.
Thyroid nodules are independent lesions in the thyroid gland, which can be single or multiple. Some of these nodules can be seen on visual inspection and palpated on palpation, and can be detected on ultrasound as distinct from the surrounding tissues; others that are not palpable are detected on ultrasound or other imaging tests that can show the anatomical structure. However, thyroid nodules that are not confirmed by ultrasound are not diagnosed as thyroid nodules even if they can be palpated.
An unpalpable nodule has the same probability of malignancy as a palpable nodule of the same size.
Evaluation and management of thyroid nodules 1. The categories of thyroid nodules that need to be evaluated are benign lesions accounting for about 95% and malignant lesions accounting for only about 5% (91% of which are differentiated thyroid cancer, medullary thyroid carcinoma accounting for 5% and undifferentiated thyroid cancer accounting for only 3%). The current academic consensus is to evaluate and manage thyroid nodules >1 cm in diameter and nodules <1 cm in diameter with suspicious signs of cancer on ultrasound, history of head and neck radiation exposure, and positive family history of thyroid cancer. Those with simple thyroid nodules <1cm only need ultrasound review for follow-up.
2. Clinical evaluation of thyroid nodules The history and physical examination are the most basic steps to assess the nature of thyroid nodules. Proper evaluation requires a detailed and complete history taking and careful physical examination of the thyroid and adjacent lymph nodes. The literature reports that more than 60% of thyroid cancers can be diagnosed by physical examination by an experienced physician.
Factors that suggest a high likelihood of malignant thyroid nodules by history and physical findings are.
① the presence of a palpable thyroid nodule at age <20 or >70 years.
② history of head and neck or whole body radiation exposure (radiation therapy for oncology or for receiving a bone marrow transplant).
③ a first-degree relative with thyroid cancer.
④ rapid nodule growth.
⑤ hoarseness of the voice.
(vi) Vocal cord paralysis.
(vii) Enlarged and fixed cervical lymph nodes ipsilateral to the nodule. Need to receive further evaluation and management.
3. Laboratory evaluation of thyroid nodules 3.1 Serum thyrotropic hormone (TSH) assay assessment of nodules >1-1.5 cm in diameter: serum TSH assay, low TSH, suggesting that the nodule may secrete thyroid hormone, and further radionuclide thyroid scan, with minimal possibility of malignancy in functioning nodules, without further thyroid fine needle aspiration cytology (FNA). TSH is normal, but elevated TSH indicates hypothyroidism and requires further measurement of thyroid autoantibodies or FNA.
3.2 Serum thyroglobulin (Tg) measurement is evaluated in most thyroid disorders and is not specific and sensitive for the diagnosis of thyroid cancer.
3.3 Serum calcitonin assay is evaluated for early detection of parathyroid cell hyperplasia and medullary thyroid carcinoma. Blood calcitonin >100 pg/mL without stimulation suggests the possible presence of medullary thyroid carcinoma.
4. Assessment of thyroid nodules by ancillary tests
4.1 Evaluation of thyroid nuclei scan Previously, thyroid nuclei imaging was the most commonly used method to assess the nature of thyroid nodules. Radionuclides (131I, 125I, 99mTc) are used for dynamic or static imaging of the thyroid gland to reflect the location, size, morphology and function of the thyroid gland and its nodules. Thyroid nodules are classified as “hot nodules”, “warm nodules” and “cold nodules” depending on the amount of nuclide taken up by the nodules. Most benign nodules, like thyroid cancer, have little uptake of nuclide, making them so-called “cold nodules” and therefore of little diagnostic value. Therefore, thyroid nuclide imaging has diagnostic value only for about 10% of hot nodules (autonomous high-functioning thyroid adenomas), while the diagnosis of the remaining 90% of nodules is still uncertain.
4.2 Ultrasonography of the thyroid gland is necessary to confirm the diagnosis of thyroid nodules, both to determine the size and number of nodules and to show the presence of cystic and cancerous signs. Its accuracy depends on the skill and experience of the examiner. Cancerous signs include microcalcifications, hypoechogenicity of solid nodules, and abundant blood supply within the nodule. It is generally accepted that anechoic lesions and homogeneous hyperechoic lesions have a low risk of cancer. However, the results of the study show that it is not yet possible to distinguish well between benign and malignant lesions based on ultrasonographic findings.
4.3 FNA is the most accurate and cost-effective method for evaluating thyroid nodules, with a 90% concordance rate between FNA results and surgical pathology, with only a 5% false negative and 5% false positive rate. The compliance rate depends on the skill and experience of the puncture operator and the cytopathologist.FNA biopsy results are divided into four categories.
① malignant nodules.
② suspected malignant nodules.
③ benign nodules.
④ Unsatisfactory specimen sampling. The latter case requires repeat puncture under ultrasound guidance.
5. The risk of malignancy for assessment of multiple thyroid nodules is the same as for isolated nodules. In the presence of more than 2 nodules >1-1.5 cm in diameter, FNA is performed on nodules with suspicious cancer signs on ultrasound; in the presence of more than 2 nodules >1-1.5 cm in diameter, FNA is performed on the largest nodule without suspicious cancer signs on ultrasound; TSH is below the normal range, thyroid nuclear imaging is performed first to assess the functional status of each nodule >1-1.5 cm, of which If the nodule is “cold” or “warm”, FNA should be performed especially if there is a suspicion of cancer on ultrasound.
In summary, the following conditions suggest the need for surgery.
①FNA of malignant nodes.
②solid nodes with unsatisfactory FNA repeatedly.
③ FNAC suspected malignant nodes.
(iv) Certain nodules, especially those with cystic changes, where FNAC specimens are always taken unsatisfactorily.
⑤Nodules with diameter >2cm and hard.
The current consensus is to perform total or near-total thyroidectomy for thyroid cancer, followed by radioiodine removal and thyroid hormone suppression therapy.
V. Follow-up and treatment of benign thyroid nodules
1. Follow-up ultrasonography review to evaluate changes in nodule size, nodule enlargement, repeat FNA, especially ultrasound-guided FNA, and decide treatment according to the results.
2. The effect of therapeutic thyroxine on benign thyroid nodules: benign nodules may shrink when levothyroxine (L-T4) is taken and TSH is suppressed in areas with low iodine intake; the above effect is not seen in areas with adequate iodine supply. Unanimous opinion does not recommend the routine use of thyroxine suppression therapy for benign thyroid nodules.
The management of thyroid nodules in children is less common than in adults, and the malignancy rate is equal to or higher than that of adults. The assessment and treatment methods are the same as those for adults (clinical assessment, laboratory assessment, assessment of ancillary tests, etc.).
The management of thyroid nodules in pregnancy is the same as in non-pregnant women, except that thyroid nucleus imaging cannot be performed. If thyroid nodules are normal or hypothyroid with thyroid nodules in pregnancy, FNA should be performed; if TSH levels are still suppressed in early pregnancy, ultrasonography and FNA should be performed after delivery; if malignant nodules are found in early pregnancy, ultrasound monitoring and nodules grow, surgery in mid-pregnancy may be an option; if nodules are stable in size by mid-pregnancy or malignant nodules are found in late pregnancy, surgery after delivery may be an option.
Conclusion: The prevalence of thyroid nodules is high, but the proportion of malignancy is small and the degree of malignancy is low; most thyroid nodules have good natural regression; there are reliable and easy methods to identify benign and malignant thyroid nodules; intervention methods and effects of thyroid nodules are limited; there is a consensus among current experts that thyroid nodules do not require active intervention. For most patients, close clinical observation and follow-up may be the most appropriate management.